Fig. 1From: Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 studyPatient distribution: Patients were recruited during the year before (between March 2010 and February 2011; pre-guidelines population) or the year after (between January 2012 and December 2012; post-guideline population) the publication, diffusion and implementation of the SOGUG Guideline programBack to article page